S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)

Detalles Bibliográficos
Autores principales: Elalfy, M, El-Beshlawy, A, Adly, A, Ebeid, F, Fradette, C, Lee, D, Temin, N, Tricta, F, Rozova, A, Hamdy, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811868/
http://dx.doi.org/10.1097/01.HS9.0000821460.57070.77
_version_ 1784644524328353792
author Elalfy, M
El-Beshlawy, A
Adly, A
Ebeid, F
Fradette, C
Lee, D
Temin, N
Tricta, F
Rozova, A
Hamdy, M
author_facet Elalfy, M
El-Beshlawy, A
Adly, A
Ebeid, F
Fradette, C
Lee, D
Temin, N
Tricta, F
Rozova, A
Hamdy, M
author_sort Elalfy, M
collection PubMed
description
format Online
Article
Text
id pubmed-8811868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88118682022-02-22 S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY) Elalfy, M El-Beshlawy, A Adly, A Ebeid, F Fradette, C Lee, D Temin, N Tricta, F Rozova, A Hamdy, M Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8811868/ http://dx.doi.org/10.1097/01.HS9.0000821460.57070.77 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Presentations
Elalfy, M
El-Beshlawy, A
Adly, A
Ebeid, F
Fradette, C
Lee, D
Temin, N
Tricta, F
Rozova, A
Hamdy, M
S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
title S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
title_full S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
title_fullStr S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
title_full_unstemmed S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
title_short S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
title_sort s123: safety and efficacy of early-start deferiprone in infants and young children with beta-thalassemia (start study)
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811868/
http://dx.doi.org/10.1097/01.HS9.0000821460.57070.77
work_keys_str_mv AT elalfym s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT elbeshlawya s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT adlya s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT ebeidf s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT fradettec s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT leed s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT teminn s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT trictaf s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT rozovaa s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy
AT hamdym s123safetyandefficacyofearlystartdeferiproneininfantsandyoungchildrenwithbetathalassemiastartstudy

Ejemplares similares